06160.HK
BeOne Medicines AG
HKSE · Healthcare · Biotechnology · CH
HKD 220.80
+1.19%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
46.7x
EV/EBITDA
33.2x
Market Cap
HKD 318.49B
MomentumView details →
1D Return
+1.19%
YTD Return
+23.15%
RSI (14)
57.2
ValuationView details →
P/E (Fwd)
46.7x
EV/EBITDA
33.2x
Market Cap
HKD 318.49B
RSI (14)
57.2
MomentumView details →
1D Return
+1.19%
YTD Return
+23.15%
Similar companies
Latest newsMore news →
President Donald J. Trump announced agreements with nine additional pharmaceutical manufacturers to lower drug prices for Americans in line with most-favored-nation pricing.4d agoBeOne Medicines announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients and strengthen its U.S. manufacturing footprint.4d ago